News | Magnetic Resonance Imaging (MRI) | July 24, 2025

Following the recent FDA clearance of the new Swoop System, two leading hospitals in the U.S. have purchased the first commercial units, marking the launch of next-generation portable MR brain imaging.

Hyperfine Announces the First Commercial Sales of the Next-Gen Portable MRI  System

July 17, 2025 – Hyperfine, Inc.recently announced the first commercial sales of the next-generation Swoop system.The Swoop system is the first FDA-cleared AI-powered portable MRI system for the brain. The Swoop system is powered by proprietary Optive AI software.

Two pioneering hospitals in the northeast U.S. plan to utilize the technology in their intensive care units and emergency department settings.

The initial sales of the next-generation Swoop system—purchased by two top-tier hospitals in the northeastern United States—demonstrate a strong market response following FDA clearance and mark a critical step toward the widespread clinical adoption of portable brain imaging with diagnostic-level clarity.

“This marks the start of a new phase for Hyperfine — one where our vision to transform MRI access is driven by a new system that is commercially ready, is clinically valuable, has outstanding image quality and functionality, and is garnering strong customer interest,” commented Maria Sainz, president and CEO of Hyperfine. “Attaining the milestone of first commercial sales and deliveries of the new Swoop system just weeks after FDA clearance is the result of seamless execution across the organization — from industry-leading product development to accelerated clearance to rapid manufacturing ramp to initial sales. We are excited about the momentum with the new Swoop system and the growth we anticipate in the second half of 2025 and beyond.”

The new Swoop system features innovations specifically engineered to deliver the highest signal-to-noise ratio, which, when paired with the Optive AI software, achieve exceptional image quality, including improved resolution, uniformity, and faster acquisition times. This new level of image quality has the potential to dramatically drive the adoption of the Swoop system across sites of care and multiple clinical applications. The new Swoop® system also delivers a user and patient-centric design to accommodate a broad patient population—especially beneficial for pediatric, elderly, or anxious patients—making MRI more accessible for all.

For more information about the Swoop Portable MR Imaging system, please visit HyperfineMRI.com.


Related Content

News | Magnetic Resonance Imaging (MRI)

April 27 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | Computed Tomography (CT)

April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time April 30, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
News | Radiology Imaging

April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in ...

Time April 23, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
Subscribe Now